Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Fradera

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Chembiochem : a European Journal of Chemical Biology|February 1, 2022
NMR Data-Driven Docking of HDM2-Inhibitor ComplexesXavier Fradera, Michael H Reutershan, Michelle R Machacek, et al.
Bioinformatics (Oxford, England)|July 16, 2002
Ligand-induced changes in the binding sites of proteinsXavier Fradera, Xavier De La Cruz, Carlos H T P Silva, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|April 17, 2012
High-resolution crystal structures of factor XIa coagulation factor in complex with nonbasic high-affinity synthetic inhibitorsXavier Fradera, Bert Kazemier, Emma Carswell, et al.
Journal of Computer-Aided Molecular Design|September 16, 2017
Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016Xavier Fradera, Andreas Verras, Yuan Hu, et al.
Journal of Computer-Aided Molecular Design|October 8, 2017
Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effortYing-Duo Gao, Yuan Hu, Alejandro Crespo, et al.
Journal of Molecular Biology|April 13, 2010
X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signalingXavier Fradera, Diep Vu, Olaf Nimz, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Dioxo-triazines as a novel series of cathepsin K inhibitorsZoran Rankovic, Jiaqiang Cai, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically importantJiaqiang Cai, Xavier Fradera, Mario van Zeeland, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Optimization of Versatile Oxindoles as Selective PI3Kδ InhibitorsJoey L Methot, Abdelghani Achab, Matthew Christopher, et al.
Nature Communications|May 21, 2021
Structural insights on ligand recognition at the human leukotriene B4 receptor 1Nairie Michaelian, Anastasiia Sadybekov, Élie Besserer-Offroy, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Chembiochem : a European Journal of Chemical Biology|February 1, 2022
NMR Data-Driven Docking of HDM2-Inhibitor ComplexesXavier Fradera, Michael H Reutershan, Michelle R Machacek, et al.
Bioinformatics (Oxford, England)|July 16, 2002
Ligand-induced changes in the binding sites of proteinsXavier Fradera, Xavier De La Cruz, Carlos H T P Silva, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|April 17, 2012
High-resolution crystal structures of factor XIa coagulation factor in complex with nonbasic high-affinity synthetic inhibitorsXavier Fradera, Bert Kazemier, Emma Carswell, et al.
Journal of Computer-Aided Molecular Design|September 16, 2017
Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016Xavier Fradera, Andreas Verras, Yuan Hu, et al.
Journal of Computer-Aided Molecular Design|October 8, 2017
Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effortYing-Duo Gao, Yuan Hu, Alejandro Crespo, et al.
Journal of Molecular Biology|April 13, 2010
X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signalingXavier Fradera, Diep Vu, Olaf Nimz, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Dioxo-triazines as a novel series of cathepsin K inhibitorsZoran Rankovic, Jiaqiang Cai, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically importantJiaqiang Cai, Xavier Fradera, Mario van Zeeland, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Optimization of Versatile Oxindoles as Selective PI3Kδ InhibitorsJoey L Methot, Abdelghani Achab, Matthew Christopher, et al.
Nature Communications|May 21, 2021
Structural insights on ligand recognition at the human leukotriene B4 receptor 1Nairie Michaelian, Anastasiia Sadybekov, Élie Besserer-Offroy, et al.
Pageof 5